BiotevsCRH

BTMD and CRH stock compared: price, dividend, valuation and results, from SEC filings.

Biote (BTMD) has a market value of $28M and CRH (CRH) $61.9B. Over the last year, with dividends, BTMD moved -65.7% and CRH -13.9%. Dividend yield: BTMD 4.21%, CRH 1.69%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    BTMD$28M

    CRH$61.9B

    CRH is 2,232 times BTMD

  • Revenue, 12 months

    BTMD$179M

    CRH$39.0B

    CRH is 218 times BTMD

  • Net income, 12 months

    BTMD-$1.9M

    CRH$3.6B

  • Operating margin

    BTMD5.0%

    CRH13.7%

    8.7 points apart

  • ROIC

    BTMD15.5%

    CRH9.2%

    6.3 points apart

  • P/E

    BTMD–

    CRH17.4

  • Dividend yield

    BTMD4.2%

    CRH1.7%

    2.5 points apart

  • 5-year return

    BTMD-90.9%

    CRH+109.9%

    200.8 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

BTMD-90.9%

CRH+109.9%

010020030020222023202420252026
Returns by period
PeriodBTMDWith dividendsCRHWith dividends
1 year since November 17, 2025-65.7%Price -65.7%-13.9%Price -15.3%
3 years since November 17, 2023-82.2%-43.7% a yearPrice -82.2%+62.5%+17.6% a yearPrice +53.8%
5 years since November 17, 2021-90.9%-38.1% a yearPrice -90.9%+109.9%+16.0% a yearPrice +83.7%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

BTMDBioteCRHCRH

Valuation

BTMDCRH
Valuation
Price$0.89$92.58
Market value$28M$61.9B
Enterprise value (EV)$139M$77.0B
P/E–17.4
P/E, 5-year median38.016.0
P/B–2.5
EV/EBIT15.514.4
Free cash flow yield26.7%4.1%

Results and growth

BTMDCRH
Results and growth
Revenue, 12 months$179M$39.0B
Net income, 12 months-$1.9M$3.6B
Free cash flow, 12 months$7.4M$2.5B
Earnings per share, 12 months-$0.10$5.32
Revenue growth, year on year-2.5%5.3%
Revenue growth a year, past+8.4%over 4 years+7.7%over 5 years
EPS growth a year, past–-47.8%over 5 years

Margins and returns on capital

BTMDCRH
Margins and returns on capital
Gross margin67.5%36.2%
Operating margin5.0%13.7%
Net margin-1.1%9.2%
ROIC15.5%9.2%
ROE–15.0%

Balance sheet

BTMDCRH
Balance sheet
Cash$8.9M$5.1B
Total debt$128M$21.6B
Net debt / EBITDA8.82.0
Interest cover–6.3×

Dividends and buybacks

BTMDCRH
Dividends and buybacks
Dividend yield4.2%1.7%
Dividend per share, 12 months$0.04$1.56
Dividend growth a year, past––
Buyback yield12.1%1.9%
Shareholder yield16.4%3.6%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: BTMD or CRH

Didn't find what you were looking for?

Ask us
Which is bigger, Biote or CRH?

By market value, CRH ($61.9B) is about 2,232.1 times Biote ($28M), at today's prices.

How did BTMD and CRH stock do over the last 5 years?

Since November 17, 2021, BTMD's price moved -90.9% and CRH's +83.7%. With dividends: BTMD -90.9% (-38.1% a year), CRH +109.9% (+16.0% a year). Past returns do not predict future ones.

Which pays the higher dividend, BTMD or CRH?

The dividend yield at today's price is 4.21% for Biote and 1.69% for CRH. Over the last twelve months they paid $0.04 and $1.56 per share.

Which has the higher profit margins, Biote or CRH?

Over the last twelve months, the net margin was -1.1% for Biote and 9.2% for CRH, and the operating margin 5.0% and 13.7%. Revenue was $179M and $39.0B.

Which is the better investment, Biote or CRH?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.